A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer

World J Gastroenterol. 2006 Oct 28;12(40):6536-9. doi: 10.3748/wjg.v12.i40.6536.

Abstract

Aim: To investigate the role of the polymorphism of p53 codon 72 in early gastric cancer (EGC) and advanced gastric cancer (AGC) in Korean patients.

Methods: DNA was extracted from blood samples of gastric cancer patients (n=291) and controls (n=216). In the p53 codon 72 genotypes were determined by PCR-RFLP.

Results: Patients with gastric cancer had a significantly higher frequency of the homozygous proline (Pro) allele than the control (P=0.032). Patients with AGC had a significantly higher frequency of the Arg/Arg (arginine) allele (P=0.038) than EGC and a similar Pro/Pro allele. The signet ring cell type had a higher frequency of the Pro/Pro allele than other types (P=0.031). The Pro/Pro genotype carries a 3.9-fold increased risk of developing gastric cancer (95% CI, 1.3-15.4, P=0.039) when compared to Arg/Arg and Arg/Pro genotypes and to develop EGC is a 5.25 fold increased risk (95% CI, 1.8-19.6, P=0.021).

Conclusion: The Pro/Pro genotype of the p53 codon 72 polymorphism carries a higher risk for gastric cancer in general and is also associated with a much higher risk for EGC than AGC.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • DNA, Neoplasm / analysis
  • DNA, Neoplasm / genetics
  • Disease Progression
  • Female
  • Genotype
  • Humans
  • Korea
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Polymorphism, Genetic*
  • Proline / analysis
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology
  • Tumor Suppressor Protein p53 / analysis
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • DNA, Neoplasm
  • Tumor Suppressor Protein p53
  • Proline